Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer

Table 2 FcγRIIa and FcγRIIIa polymorphism frequencies in healthy subjects and tumor patients

	HS	Men	Women		Men	Women		Men	Women
	H/H			H/R			R/R
V/V	38.89	40.00	38.46	9.01	11.11	7.70	8.33	16.67	0.00
V/F	55.55	40.00	61.54	68.18	55.55	76.92	75.00	83.33	66.67
F/F	5.50	20.00	0.00	22.72	33.33	15.38	16.67	0.00	33.33
	TP
V/V	25.00	33.33	0.00	6.67	12.50	0.00	0.00	0.00	0.00
V/F	75.00	66.67	100.00	80.00	75.00	85.71	100.00	100.00	100.00
F/F	0.00	0.00	0.00	13.33	12.50	14.28	0.00	0.00	0.00
	HS vs TP
V/V	P = 0.035	NS	P < 0.0001	NS	NS	P = 0.004	P = 0.0033	P < 0.0001	NS
V/F	P = 0.004	P = 0.0002	P < 0.0001	NS	P = 0.004	NS	P < 0.0001	P < 0.0001	P < 0.0001
F/F	P = 0.017	P < 0.0001	NS	NS	P = 0.0005	NS	P < 0.0001	NS	P < 0.0001

Values are expressed as percentages. The statistical data were obtained by using χ² of goodness-of-fit statistic. Values of P < 0.05 were considered significant. NS: Not significant; HS: Healthy subject; TP: Tumor patients.